期刊文献+

系统性红斑狼疮与血栓/栓塞 被引量:3

Thrombosis/embolism and systemic lupus erythenatosus
暂未订购
导出
摘要 目的分析系统性红斑狼疮(SLE)患者并发血栓/栓塞的情况,以探讨SLE患者易发血栓的相关因素。方法回顾性分析了近6年北京协和医院收治的1091例SLE患者并发血栓/栓塞的情况,以及当时SLE活动情况(SLE疾病活动指数,SLEDAI)、抗磷脂抗体(APA)、抗内皮细胞抗体(AECA)、低蛋白血症、高球蛋白血症等因素。血栓/栓塞的诊断主要依靠同位素肺通气/灌注(V/Q)显像、CT、核磁共振(MRI)、血管彩超、核磁共振血管显像(MBA)、血管造影及病理学等检查方法。结果 1091例SLE患者中59例(5.4%)并发血栓/栓塞;死亡5例,占并发血栓/栓塞者的8.5%。血栓/栓塞最常累及的器官包括下肢深静脉(34.4%)、中枢神经系统(29.5%)和肺(21.3%)。并发血栓/栓塞的患者其SLE疾病活动度明显高于无血栓/栓塞者(SLEDAI:16.6±7.02 vs 9.7±5.9分,t检验,P<0.05);同时,并发血栓/栓塞者抗磷脂抗体(APA)阳性率明显高于对照组(54.2%vs 29.5%,卡方检验,P<0.001)。胆固醇(TC)增高和低密度脂蛋白(LDL)增高者在合并血栓/栓塞者中发生率明显高于无血栓/栓塞组(P<0.01)。结论 SLE并发血栓和/或栓塞是SLE患者的重要临床表现,为SLE死亡的主要原因之一。SLE疾病明显活动、APA阳性、胆固醇及LDL增高是血栓/栓塞的易患因素。 Objective To evaluate the thrombosis/embolism in patients with systemic lupus erythematosus (SLE) and analyze the risk factors associated with thrombosis.Methods A total of 1091 SLE patients,who admitted to PUMC hospital during the recent 6 years were collected.The patients with thrombosis and/or embolism were confirmed by imagine or Doppler studies or histopathologic studies.Disease activity of SLE recorded as SLE disease activity index (SLEDAI).Results 59 patients had thrombotic events,account for 5.4% of SLE patients.5 of the 59 patients dead,the mortality was 8.5%.The most involved organs with thrombotic events were lower extremities (34.4%),central nerve system (29.5%) and lung (21.3%).Disease activity in patients with thrombotic events was significantly higher than the patients without thrombotic events (SLEDAI:16.6±7.02 vs 9.7±5.9,t test P<0.05);anti-phospholipid antibodies (APA) was significantly higher in patients with thrombotic events (54.2% vs 29.5% controls,Chi square test,P<0.001);hypercholesterolemia and increased low density lipoprotein were more frequently found in patients with thrombotic events (P< 0.01).Conclusions Patients with SLE had high incidence of thrombosis/ embolism.The thrombotic events were primarily a cause of death in SLE patients.High disease activity,APA (+),hypercholesterolemia and increased low density lipoprotein could be risk factors in the development of thrombotic episodes.
出处 《医学研究通讯》 2004年第3期12-15,共4页 Bulletin of Medical Research
基金 首都医学发展科研基金(首都ZD199801)
关键词 系统性红斑狼疮 血栓 栓塞 回顾性分析 抗磷脂抗体 抗内皮细胞抗体 Systemic lupus erythematosus Thrombosis Embolism
  • 相关文献

参考文献5

  • 1Buyon JP, et al. Clinical and laboratory features in Kpippel JH ed: Primer on the rheumatic diseases. Arthritis Foundation, Atlanta, 2001.335-346.
  • 2Amigo MC, et al. Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am, 2000, 26 (2) :331-348.
  • 3Meroni PL, et al. Pathogenic mechanisms Mediating Antiphospholipid syndrome. Curr Opin Rheumatol, 2001,13: 377-382.
  • 4Karassa FB, et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med, 2000, 93 : 169 - 174.
  • 5Natusch A, et al. Thrombotic thrombocytopenia purpura- a rare cause of thrombocytopenic in systemic lupus erythematosus.Dtsch Med Wochenschr,2002, 127 (37) :1881-1885.

同被引文献32

  • 1Francesca R Ponziani,Maria A Zocco,Chiara Campanale,Emanuele Rinninella,Annalisa Tortora,Luca Di Maurizio,Giuseppe Bombardieri,Raimondo De Cristofaro,Anna M De Gaetano,Raffaele Landolfi,Antonio Gasbarrini.Portal vein thrombosis:Insight into physiopathology,diagnosis,and treatment[J].World Journal of Gastroenterology,2010,16(2):143-155. 被引量:81
  • 2Manger K,Manger B,Repp R,et al.Definition of risk factors for death,end stage renal disease,and thromboembolic events in a monocontric cohort of 338 patients with systemic lupus erythematosus[J].Ann Rheum Dis,2002,61(12):1065-1070.
  • 3Sarabi ZS,Chang E,Bobba R.et al.Incidence Fates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus[J].Arthritis Rheum,2005,53(4):609-612.
  • 4Tektonidou MG,Laskari K,Panagiotakos DB,et al.Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies[J].Ar-thrifts Rheum,2009,61(1):29-36.
  • 5Keeling DM,Isenberg DA.Haematological manifestations of systemic lupus erythematosus.Blood Rev,1993,7(4):199-207.
  • 6John HK,John HS,Leslie JC,et al.Primer on the Rheumatic Diseases.13th edition.Springer.312.
  • 7Lee SL,Miotti AB.Disorders of hemostatic function in patients with systemic lupus erythematosus.Semin Arthritis Rheum,1975,4(3):241-252.
  • 8Liebman H.Other immune thrombocytopenias.Semin Hematol,2007,44(4 Suppl 5):24-34.
  • 9Ayoub O,Aljurf M,Al Nounou R,et al.Systemic lupus erythematosus presenting with haemorrhagic manifestation.Clin Lab Haematol,1999,21(6):413-416.
  • 10Franchini M,Gandini G,Di Paolantonio T,et al.Acquired hemophilia A:a concise review.Am J Hematol,2005,80(1):55-63.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部